| Name | Title | Contact Details |
|---|
Synthetic Biologics, Inc. trades on the NYSE MKT, LLC under the symbol "SYN". The Company`s principal executive offices are located in Rockville, MD, and the finance and administrative office is located in Ann Arbor, MI. Synthetic Biologics, Inc. is a microbiome-focused, clinical-stage company developing therapeutics to protect the microbiome while targeting pathogen-specific diseases. The Company`s lead candidates in Phase 2 development include SYN-004 which is designed to protect the gut microbiome from the effects of certain commonly used intravenous (IV) antibiotics for the prevention of C. difficile infection and antibiotic-associated diarrhea (AAD), and SYN-010 which is intended to reduce the impact of methane producing organisms in the gut microbiome to treat the underlying cause of irritable bowel syndrome with constipation (IBS-C). In addition, the Company is developing a monoclonal antibody combination for the treatment of Pertussis, and a Phase 2 oral estriol drug for the treatment of relapsing-remitting multiple sclerosis (MS) and cognitive dysfunction in MS.
BlueCross BlueShield of Louisiana is a Baton Rouge, LA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Wellbridge is a Greenwood Vlg, CO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Operatrix Consulting Inc. is a Waterdown, ON-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
At SmartPractice, our mission is to improve world health by improving health care practices. Our focus is on helping you create practice conditions that allow you to interact with more patients.